| C1S |
C1S: Complement C1s subcomponent precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
0.67 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
0.67 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
0.67 |
Evidence |
|
| HCK |
IPI00029769 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
0.67 |
Evidence |
|
| CTSG |
CTSG: Cathepsin G precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
0.67 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.67 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
GNAI2 |
Galphai2 protein |
0.67 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
0.67 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
0.67 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
0.67 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
KLK6 |
KLK6, PRSS18, PRSS9: Kallikrein-6 precursor |
0.67 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
KLK6 |
KLK6, PRSS18, PRSS9: Kallikrein-6 precursor |
0.67 |
Evidence |
|
| TF |
TF, PRO1400: Serotransferrin precursor |
IGFBP5 |
IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor |
0.67 |
Evidence |
O
|
| SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
KLK6 |
KLK6, PRSS18, PRSS9: Kallikrein-6 precursor |
0.67 |
Evidence |
|
| C1R |
C1R: Complement C1r subcomponent precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
0.67 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.67 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
BMX |
IPI00514142 |
0.67 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
0.67 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.67 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.67 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
0.67 |
Evidence |
|
| OR10H3 |
OR10H3: Olfactory receptor 10H3 |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
0.67 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
0.67 |
Evidence |
|
| TNFSF12 |
TNFSF12, APO3L, UNQ181/PRO207, DR3LG: Tumor necrosis factor ligand superfamily m |
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
0.67 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
0.67 |
Evidence |
|